Authors: Short, SC Traish, D Dowe, A Hines, F Gore, M Brada, M

Citation: Sc. Short et al., Thalidomide as an anti-angiogenic agent in relapsed gliomas, J NEURO-ONC, 51(1), 2001, pp. 41-45

Authors: Singh, R Eeles, RA Durocher, F Simard, J Edwards, S Badzioch, M Kote-Jarai, Z Teare, D Ford, D Dearnaley, D Ardern-Jones, A Murkin, A Dowe, A Shearer, R Kelly, J Labrie, F Easton, D Narod, SA Tonin, PN Foulkes, WD

Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247

Authors: Forrest, MS Edwards, SM Hamoud, RA Dearnaley, DP Arden-Jones, A Dowe, A Kelly, J Teara, MD Easton, DF Knowles, MA Bishop, DT Eeles, RA

Citation: Ms. Forrest et al., No evidence of germline PTEN mutations in familial prostate cancer, J MED GENET, 37(3), 2000, pp. 210-212

Authors: Edwards, SM Badzioch, MD Minter, R Hamoudi, R Collins, N Ardern-Jones, A Dowe, A Osborne, S Kelly, J Shearer, R Easton, DF Saunders, GF Dearnaley, DP Eeles, RA

Citation: Sm. Edwards et al., Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival, INT J CANC, 84(5), 1999, pp. 458-465